Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinical experience with Optivate®, high-purity factor VIII (FVIII) product with von Willebrand factor (VWF) in young children with haemophilia A.
Haemophilia : the official journal of the World Federation of Hemophilia·2011
Experience with Optivate®, a new high purity concentrate of factor VIII with von Willebrand factor, in patients undergoing surgery.
Haemophilia : the official journal of the World Federation of Hemophilia·2011
Efficacy and safety of a new immunoglobulin G product, Gammaplex(®), in primary immunodeficiency diseases.
Clinical and experimental immunology·2010
The clearance kinetics of autologous RhD-positive erythrocytes coated ex vivo with novel recombinant and monoclonal anti-D antibodies.
Clinical and experimental immunology·2007
A retrospective survey on the safety of Replenate, a high-purity factor VIII concentrate.
Pharmacoepidemiology and drug safety·2004
A retrospective survey on the safety of Replenine, a high-purity factor IX concentrate.
Pharmacoepidemiology and drug safety·2004
Subchronic kretek smoke exposure induces myocardial p53 protein expression and associated inflammatory and fibrotic alterations in rats.
Journal of advanced pharmaceutical technology & research·2026
Correction: MCL-1 as a tumor microenvironment-linked survival node in cholangiocarcinoma.
Frontiers in oncology·2026